KẾT QUẢ PHẪU THUẬT CẮT GAN TRUNG TÂM ĐIỀU TRỊ UNG THƯ BIỂU MÔ TẾ BÀO GAN TẠI BỆNH VIỆN TRUNG ƯƠNG QUÂN ĐỘI 108

Abstract

Objectives: To evaluate the outcomes of central hepatectomy for hepatocellular carcinoma (HCC). Methods: A cross-sectional descriptive study was conducted on 33 patients who underwent central hepatectomy from January 2020 to January 2025 at the Department of Hepatobiliary - Pancreas Surgery, 108 Military Central Hospital. Results: The open/laparoscopic surgery ratio was 2.67/1. The mean operative time was 189.1 ± 62.9 minutes, with a parenchymal transection time of 62.7 ± 18.8 minutes. The average blood loss was 256.7 ± 119.3mL, with no intraoperative blood transfusion required. The R0 resection rate was 100%. Common complications included bile leakage (9%), liver failure (6%), and fluid collection (6%), Clavien-Dindo grade 3 complications accounted for 12%. The mean postoperative hospital stay was 7.8 ± 2.0 days. No 30-day postoperative mortality was observed. The mean overall survival (OS) time was 45.2 ± 5.7 months, and disease-free survival (DFS) time was 36.4 ± 6.0 months. The 1-year and 3-year overall survival rates were 93.3% and 62.8%, respectively. Conclusion: Central  hepatectomy is a safe and effective surgical approach that improves survival outcomes in patients with centrally located HCC.